v3 Template
A
Antiverse
Biotechnology / Drug Discovery
Founded
--
Employees
--
Total Funding
$16.9M
Funding Rounds
3
Last Funding
2026-03-03
About Antiverse
Antiverse is an AI-driven techbio company based in Cardiff, UK, with offices in Boston, MA, specializing in antibody design for challenging drug targets such as G-protein coupled receptors and ion channels. The company combines machine learning and advanced cell line engineering to develop de novo antibody therapeutics, collaborating with top global pharmaceutical companies and building a strong internal pipeline across various indications.
Products & Services
Computational Antibody Design Technology:Next-generation technology using machine learning to design antibodies for challenging targets like G-protein coupled receptors and ion channels, reducing the timeline from target identification to functional antibody to just 6 months.
Target-Specific Antibody Libraries:Designed for each target using models to predict high-binding probability sequences without pre-existing data.
Screening and Multiparameter Clustering:Deep sequencing and clustering of antibody sequences across 20 properties to identify lead candidates for functional validation.
Specialties
Antibody Design
Machine Learning in Drug Discovery
G-Protein Coupled Receptors (GPCRs)
Ion Channels
Computational Drug Discovery
AI-Driven Therapeutics
antibody design
GPCRs
ion channels
generative AI models
cell line engineering
de novo therapeutics
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Series A T: - FT: Series A |
A: 9300000 MR: - FA: 9.3 million FAN: 9300000 |
D: 2026-03-03 FD: 2026-03-03 |
6 investors |
| 2 |
RT: Seed T: - FT: Seed |
A: 4600000 MR: - FA: $4.6M FAN: 4600000 |
D: 2024-10-15 FD: 2024-10-15 |
6 investors |
| 3 |
RT: Seed T: - FT: Seed |
A: 3000000 MR: - FA: 3 million USD FAN: 3000000 |
D: 2023-03-02 FD: 2023-03-02 |
8 investors |
Series A
Latest
2026-03-03
$9.3M
6 investors (Pro only)
Seed
2024-10-15
$4.6M
Seed
2023-03-02
$3.0M
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
Antiverse Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- antiverse.io
- Industries
- Biotechnology / Drug Discovery
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro